National Survey on Infiltrative Breast Cancer

Completed

• Conditions: Infiltrative Breast Cancer

• Registration Number: NCT00696527
• Lead Sponsor: AstraZeneca

Brief Summary

The purpose of this observational study is to describe radiological, clinical and histological characteristics of women with infiltrative breast cancer.

Detailed Description

Not available

Study Timeline

• Study Start: 2007-06
• Study First Submitted: 2008-06-10
• Study First Submitted QC: 2008-06-11
• Study First Posted: 2008-06-12
• Primary Completion: 2008-07
• Study Completion: 2008-07
• Status Verified: 2010-12
• Last Update Submitted: 2010-12-09
• Last Update Posted: 2010-12-10

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 1500

Inclusion Criteria

• Women> or = 18 years old
• Women with newly diagnosis of infiltrative breast cancer
• Agree to take part in this study

Exclusion Criteria

• Women with other malignant tumor (except in situ cervical carcinoma or treated basal cell carcinoma)
• Women with in situ ductal carcinoma or in situ lobular carcinoma

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Radiological, Clinical and Histological characteristics	Once

Secondary Outcome Measures

Name	Time	Method
Treatments: Surgery, radiotherapy, chemotherapy, hormonotherapy.	Once

Trial Locations

Locations (1)

Research Site; 🇫🇷 Villejuif Cedex, France